Julia Strandberg - 03 Dec 2021 Form 3 Insider Report for Pear Therapeutics, Inc. (PEARQ)

Role: Chief Commercial Officer
Signature: /s/ Stacie S. Aarestad, Attorney-in-fact
Issuer symbol: PEARQ
Transactions as of: 03 Dec 2021
Transactions value $: $0
Form type: 3
Filing time: 07 Dec 2021, 16:07:11 UTC
Next filing: 18 Feb 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No Securities Beneficially Owned. Exhibit 24 Power of Attorney filed herewith.